Publication | Open Access
Camrelizumab vs Placebo in Combination With Chemotherapy as Neoadjuvant Treatment in Patients With Early or Locally Advanced Triple-Negative Breast Cancer
33
Citations
30
References
2024
Year
ClinicalTrials.gov Identifier: NCT04613674.
| Year | Citations | |
|---|---|---|
Page 1
Page 1